Payments to Acquire Property, Plant, and Equipment of ImmunityBio, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
ImmunityBio, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • ImmunityBio, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,121,000, a 11% decline year-over-year.
  • ImmunityBio, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $3,846,000, a 44% decline from 2024.
  • ImmunityBio, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $6,888,000, a 77% decline from 2023.
  • ImmunityBio, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $30,584,000, a 61% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

ImmunityBio, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $3,846,000 -$3,042,000 -44% 01 Jan 2025 31 Dec 2025 10-K 23 Feb 2026 2025 FY
2024 $6,888,000 -$23,696,000 -77% 01 Jan 2024 31 Dec 2024 10-K 23 Feb 2026 2025 FY
2023 $30,584,000 -$47,578,000 -61% 01 Jan 2023 31 Dec 2023 10-K 23 Feb 2026 2025 FY
2022 $78,162,000 +$44,599,000 +133% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $33,563,000 +$31,894,000 +1911% 01 Jan 2021 31 Dec 2021 10-K 19 Mar 2024 2023 FY
2020 $1,669,000 -$2,618,000 -61% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $4,287,000 -$8,815,000 -67% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $13,102,000 -$21,713,000 -62% 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2021 2020 FY
2017 $34,815,000 +$28,255,000 +431% 01 Jan 2017 31 Dec 2017 10-K 25 Mar 2020 2019 FY
2016 $6,560,000 +$4,319,000 +193% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2019 2018 FY
2015 $2,241,000 +$2,006,000 +854% 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
2014 $235,000 +$232,000 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $3,000* 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2016 2015 FY

ImmunityBio, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,121,000 -$140,000 -11% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $1,261,000 -$7,167,000 -85% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $8,428,000 -$18,919,000 -69% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $27,347,000 +$20,264,000 +286% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $7,083,000 +$6,768,000 +2149% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $315,000 -$1,789,000 -85% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q1 2019 $2,104,000 -$2,798,000 -57% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $4,902,000 +$393,000 +8.7% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $4,509,000 +$3,442,000 +323% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q1
Q1 2016 $1,067,000 +$1,029,000 +2708% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q1 2015 $38,000 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.